|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
CAH | Giacomin Jon L | CEO, Medical Segment | Aug 20 | Sale | 51.95 | 2,890 | 150,136 | 72,652 | Aug 21 04:08 PM |
CAH | Giacomin Jon L | CEO, Medical Segment | Feb 20 | Sale | 68.78 | 7,995 | 549,924 | 55,048 | Feb 20 05:54 PM |
CAH | Giacomin Jon L | CEO, Pharmaceutical Segment | May 12 | Option Exercise | 41.60 | 23,270 | 968,032 | 55,440 | May 15 04:59 PM |
CAH | Giacomin Jon L | CEO, Pharmaceutical Segment | May 12 | Sale | 72.87 | 23,270 | 1,695,685 | 32,170 | May 15 04:59 PM |
CAH | Giacomin Jon L | CEO, Pharmaceutical Segment | Aug 16 | Option Exercise | 28.20 | 39,681 | 1,119,128 | 80,266 | Aug 17 04:31 PM |
CAH | Giacomin Jon L | CEO, Pharmaceutical Segment | Aug 16 | Sale | 82.77 | 47,251 | 3,910,965 | 33,015 | Aug 17 04:31 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite